title: Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker.
authors.forename: H
authors.initials: H
authors.lastname: Masoudi
authors.forename: D J
authors.initials: DJ
authors.lastname: Van Niekerk
authors.forename: C B
authors.initials: CB
authors.lastname: Gilks
authors.forename: M
authors.initials: M
authors.lastname: Cheang
authors.forename: K
authors.initials: K
authors.lastname: Bilek
authors.forename: U
authors.initials: U
authors.lastname: Fischer
authors.forename: T
authors.initials: T
authors.lastname: Ehlen
authors.forename: D
authors.initials: D
authors.lastname: Miller
authors.forename: L C
authors.initials: LC
authors.lastname: Horn
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000401:mortality / Q000556:secondary; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism*; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D011379:Prognosis; D015996:Survival Rate; D046888:Tissue Array Analysis; D002583:Uterine Cervical Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D019941:Cyclin-Dependent Kinase Inhibitor p16